- Investing Ideas
- /
- U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
U.K. Pharmaceuticals & Biotech Potentially Undervalued Companies
Results
195
Companies with a Value score of at least 3, ordered by Value score
195 companies
Hansa Biopharma
Market Cap: SEK 2.8b
A biopharmaceutical company, engages in development and commercialization of treatments for patients with rare immunological conditions in Sweden, North America, and rest of Europe.
0RC7
SEK 33.20
7D
7.0%
1Y
-17.5%
GSK
Market Cap: UK£59.8b
Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.
GSKL
UK£14.87
7D
0.9%
1Y
-2.5%
Amgen
Market Cap: US$150.3b
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.
0R0T
US$278.75
7D
1.3%
1Y
-12.1%
Illumina
Market Cap: US$14.5b
Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.
0J8Z
US$94.58
7D
-7.3%
1Y
-27.3%
Ultragenyx Pharmaceutical
Market Cap: US$2.8b
A biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Latin America, Europe, the Middle East, Africa, and the Asia-Pacific.
0LIF
US$28.71
7D
-0.4%
1Y
-48.0%
Dermapharm Holding
Market Cap: €1.9b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
DMPD
€38.88
7D
0%
1Y
n/a
Vetoquinol
Market Cap: €1.2b
A veterinary pharmaceutical company, designs, develops, and sells veterinary drugs and non-medicinal products in Europe, the Americas, and the Asia Pacific region.
VETOP
€100.60
7D
0%
1Y
n/a
Vertex Pharmaceuticals
Market Cap: €97.4b
A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).
VX1D
€339.70
7D
0%
1Y
n/a
Gerresheimer
Market Cap: €1.3b
Provides medicine packaging, drug delivery devices, and solutions in Germany and internationally.
GXID
€35.88
7D
-15.4%
1Y
-63.0%
Navamedic
Market Cap: NOK 379.7m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
0FDB
NOK 25.20
7D
0%
1Y
n/a
Dermapharm Holding
Market Cap: €1.7b
Manufactures and sells off-patent branded pharmaceutical products in Germany, France, Spain, Austria, Switzerland, and internationally.
0A5J
€32.15
7D
-1.1%
1Y
-3.3%
Azenta
Market Cap: US$1.4b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
0HQ1
US$31.64
7D
2.1%
1Y
-32.8%
Valneva
Market Cap: €766.9m
A specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs.
0OB3
€4.38
7D
4.6%
1Y
62.7%
Gilead Sciences
Market Cap: US$141.0b
A biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally.
0QYQ
US$112.84
7D
-0.4%
1Y
36.6%
MPH Health Care
Market Cap: €80.7m
An investment company, engages in the healthcare business in Germany.
0W1Q
€18.20
7D
-5.7%
1Y
-26.0%
LadRx
Market Cap: US$925.8k
A biopharmaceutical company, engages in research and development of chemotherapeutic drugs for solid tumors in the United States.
0I5R
US$1.00
7D
0%
1Y
n/a
Charles River Laboratories International
Market Cap: US$6.7b
Charles River Laboratories International, Inc.
0ADA
US$166.81
7D
0%
1Y
n/a
H. Lundbeck
Market Cap: DKK 42.8b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUNBC
DKK 44.81
7D
5.6%
1Y
n/a
Merck
Market Cap: €199.7b
Operates as a healthcare company worldwide.
6MKD
€73.80
7D
0%
1Y
-28.3%
Virbac
Market Cap: €2.6b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
0NM7
€312.50
7D
0.6%
1Y
-19.4%
Bristol-Myers Squibb
Market Cap: €91.4b
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
BRMD
€37.86
7D
-4.1%
1Y
-14.9%
Myriad Genetics
Market Cap: US$716.4m
A molecular diagnostic testing and precision medicine company, develops and provides molecular tests.
0K3W
US$7.63
7D
1.6%
1Y
-71.5%
Merck KGaA
Market Cap: €47.0b
Operates as a science and technology company in Germany.
MRKD
€109.50
7D
2.0%
1Y
-29.5%
HUTCHMED (China)
Market Cap: UK£2.0b
HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.
HCML
UK£2.54
7D
-4.3%
1Y
n/a
Vistin Pharma
Market Cap: NOK 1.0b
Through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide.
0RAM
NOK 23.30
7D
-2.1%
1Y
n/a
Swedish Orphan Biovitrum
Market Cap: SEK 96.3b
A biopharma company, provides medicines in the areas of haematology, immunology, and specialty care in Europe, North America, the Middle East, Asia, and Australia.
0MTD
SEK 276.14
7D
0.2%
1Y
-14.7%
Xbrane Biopharma
Market Cap: SEK 413.0m
A biotechnology company, engages in the development, manufacture, and sale of biosimilars.
XBRANS
SEK 0.39
7D
0%
1Y
-99.5%
Circio Holding
Market Cap: NOK 20.5m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNAO
NOK 2.52
7D
0%
1Y
n/a
Krka d. d
Market Cap: €5.9b
A generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally.
0HLK
€173.84
7D
0%
1Y
n/a
Bavarian Nordic
Market Cap: DKK 18.1b
Develops, manufactures, and supplies life-saving vaccines.
BAVAC
DKK 235.50
7D
0%
1Y
-5.9%
Bioventix
Market Cap: UK£130.6m
Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.
BVXP
UK£25.00
7D
2.7%
1Y
-36.7%
AstraZeneca
Market Cap: UK£173.8b
A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.
AZNL
UK£112.16
7D
-1.4%
1Y
-2.9%
Virbac
Market Cap: €2.6b
Manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, and the Pacific.
VIRPP
€314.25
7D
-0.08%
1Y
n/a
Bayer
Market Cap: €27.1b
Operates as a life science company worldwide.
BAYND
€27.27
7D
0.4%
1Y
-5.6%
CRISPR Therapeutics
Market Cap: US$5.6b
A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
0VRQ
US$60.39
7D
-2.1%
1Y
31.2%
Axsome Therapeutics
Market Cap: US$5.9b
A biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States.
0HKF
US$118.05
7D
1.5%
1Y
32.3%